We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

175 hedge funds and large institutions have $801M invested in Ariad Pharmaceuticals Inc in 2015 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 62 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more call options, than puts

Call options by funds: $14.3M | Put options by funds: $12.5M

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

8% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 24

1% less funds holding

Funds holding: 177 → 175 (-2)

16% less repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 62

31% less capital invested

Capital invested by funds: $1.16B → $801M (-$358M)

Holders
175
Holders Change
-2
Holders Change %
-1.13%
% of All Funds
4.89%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.14%
New
22
Increased
52
Reduced
62
Closed
24
Calls
$14.3M
Puts
$12.5M
Net Calls
+$1.83M
Net Calls Change
+$2.71M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$86.4M
2
HI
HBK Investments
Texas
+$7.71M
3
DCM
Dynamic Capital Management
Jersey
+$4.5M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$3.62M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.94M

Top Sellers

Rank Fund Capital Flow
1
DCM
Discovery Capital Management
Connecticut
-$43.9M
2
Invesco
Invesco
Georgia
-$19.7M
3
Renaissance Technologies
Renaissance Technologies
New York
-$16M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$11.6M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$6.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
GC
26
Guggenheim Capital
Illinois
$4.4M -$708K -91,936 -11%
TCIM
27
TIAA CREF Investment Management
New York
$4.35M -$562K -72,971 -9%
MFP
28
Michael F. Price
$4.18M +$1.28M +166,500 +30%
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$4.18M +$2.94M +381,333 +114%
GPCM
30
Granite Point Capital Management
Massachusetts
$3.71M -$545K -70,808 -10%
JCM
31
JS Capital Management
New York
$3.53M -$231K -30,000 -5%
Goldman Sachs
32
Goldman Sachs
New York
$3.5M -$1.56M -201,952 -25%
DCM
33
Dynamic Capital Management
Jersey
$3.41M +$4.5M +583,841 New
IIM
34
Ironwood Investment Management
Massachusetts
$3.39M -$1.43M -185,696 -24%
Charles Schwab
35
Charles Schwab
California
$3.38M +$288K +37,445 +7%
BIM
36
BlackRock Investment Management
Delaware
$3.28M -$48.2K -6,255 -1%
CS
37
Credit Suisse
Switzerland
$3.02M -$1.01M -131,234 -20%
BAMS
38
Bellevue Asset Management (Switzerland)
Switzerland
$2.89M – – –
Millennium Management
39
Millennium Management
New York
$2.76M -$1.55M -201,005 -30%
PA
40
Perceptive Advisors
New York
$2.63M +$1.99M +258,051 +134%
RPAM
41
Rhenman & Partners Asset Management
Sweden
$2.51M -$154K -20,000 -4%
FM
42
Family Management
New York
$2.47M +$77K +10,000 +2%
PPA
43
Parametric Portfolio Associates
Washington
$2.35M -$57.5K -7,466 -2%
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$2.25M – – –
RA
45
Royce & Associates
New York
$2.19M – – –
JP Morgan Chase
46
JP Morgan Chase
New York
$2.12M -$1.66M -215,527 -37%
AllianceBernstein
47
AllianceBernstein
Tennessee
$1.81M -$2.85K -370 -0.1%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$1.78M -$3.85K -500 -0.2%
TA
49
Teachers Advisors
New York
$1.76M +$436K +56,633 +23%
Wellington Management Group
50
Wellington Management Group
Massachusetts
$1.75M +$1.29M +168,064 +128%
1
2
3 4 5

ARIA Hedge Fund Activity: Q3 2015 in Review

175 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q3 2015, worth a combined $801M — down 31% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of ARIA and 22 opened new positions — a net loss of 2 holders — while 62 trimmed existing stakes and 52 added.

The largest buyer was Putnam Investments, adding an estimated $86.4M. The largest seller was Discovery Capital Management, exiting entirely with an estimated $43.9M sold.

  • 175 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q3 2015, down from 177 in Q2 2015.
  • Funds reported $801M of Ariad Pharmaceuticals Inc stock for Q3 2015, down 31% quarter-over-quarter.
  • 22 funds opened new Ariad Pharmaceuticals Inc positions in Q3 2015 and 24 closed out, a net change of -2 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q3 2015 was Putnam Investments, an estimated $86.4M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q3 2015 was Discovery Capital Management, an estimated $43.9M sold.

Based on aggregated 13F filings for Q3 2015.